Patent · US Active

Inhibitors of VEGF receptor and HGF receptor signaling

US7790729B2 · kind B2 · utility

1Cited by
5References
55Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 19, 2006
Grant dateSep 7, 2010
Priority date
Expiry dateOct 17, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.